Experimental glomerulosclerosis: Defektheilung of the kidney

Artificial Organs

Volumn 20, Issue 6, 1996, Pages 445-450

  Schiller, Brigitte ^a   Moran, John ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

cytokines; glomerulosclerosis; monocyte chemoattractant protein 1; transforming growth factor ; wound healing

Indexed keywords

BODY FLUIDS; PROTEINS;

CHEMOATTRACTANTS; CYTOKINES; EXTRACELLULAR MATRIX FORMATION; GLOMERULOSCLEROSIS; KIDNEY DISEASE; MONOCYTE CHEMOATTRACTANT PROTEIN 1; RENAL DISEASE; TRANSFORMING GROWTH FACTOR-Β; TRANSFORMING GROWTH FACTORS; WOUND HEALING;

CELL PROLIFERATION;

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

CONFERENCE PAPER; GLOMERULOSCLEROSIS; HUMAN; PRIORITY JOURNAL; PROGNOSIS; WOUND HEALING;

ANIMALIA;

EID: 0029894070     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04530.x     Document Type: Conference Paper

References (50)

1. Lovett DH, Larsen A. Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. J Immunol 1988;134:1796-801.
2. Abboud HE, Poptic E, DiCorleto P. Production of platelet-derived growth factor-like protein by rat mesangial cells in culture. J Clin Invest 1987;80:675-83.
3. McKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor-β. J Clin Invest 1989;83:1160-7.
4. Frank J, Engler-Blum G, Rodemann HP, Müller GA. Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1993;1: 26-35.
5. Hook DH, Gee DC, Atkins RC. Leucocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;31:964-73.
6. Markovic-Lipkovski J, Müller CA, Risler T, Bohle A, Müller GA. Glomerular and interstitial infiltrates of mononuclear leukocytes in glomerulonephritis. Nephrol Dial Transplant 1990;5:10-7.
7. Bohle A, Mackensen-Haen S, von Gise H, Grund KE, Wehrmann M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C, Müller G. The consequences of tubulointerstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990;186: 135-44.
8. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 1990;37:689-95.
9. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β. Kidney Int 1992;41: 1213-21.
10. Sporn MB, Roberts AB. Peptide growth factors and inflammation, tissue repair and cancer. J Clin Invest 1986;78: 329-32.
11. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and the proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990;86:453-62.
12. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346:371-4.
13. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360:361-3.
14. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-27.
15. Coimbra T, Wiggins R, Noh WJ, Merritt S, Phan SH. Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991;138: 223-34.
16. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-8.
17. Schiller B, DeLeo M, Warren E, Moran J. Focal glomerulosclerosis in the remnant kidney model: an inflammatory disease mediated by cytokines (abstract). Kidney Int 1994; 46:938.
18. Muchaneta-Kubara EC, Sayed-Ahmed N, El Nahas AM. Subtotal nephrectomy: a mosaic of growth factors. Nephrol Dial Transpl 1995;10:320-7.
19. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M. TGF-β in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994;45: 525-36.
20. Ding G, Pesek-Diamond I, Diamond JR. Cholesterol, macrophages, and gene expression of TGF-β and fibronectin during nephrosis. Am J Physiol 1993;264:F577-84.
21. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 1992;141: 1381-96.
22. Schiller B, Moran J. Modulation of cytokine and fibronectin expression in an animal model of focal glomerulosclerosis by a low protein diet (abstract). Kidney Int 1994;46:938.
23. Eddy AA. Protein restriction reduces transforming growth factor-β and interstitial fibrosis in nephrotic syndrome. Am J Physiol 1994;35:F884-93.
24. Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H. Low protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 1993;121:224-34.
25. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β and platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-601.
26. Bruijin JA, Roos A, De Geus B, De Heer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 1994;123:34-7.
27. Cattell V. Macrophages in acute glomerular inflammation (editorial review). Kidney Int 1994;45:945-52.
28. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 1989;35:778-82.
29. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-26.
30. Schreiner GF. The role of macrophages in glomerular injury. Semin Nephrol 1991;11:268-75.
31. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
32. Nelken NA, Coughlin SR, Gordon D, Valente AJ. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-5.
33. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33:917-24.
34. Stahl RA, Thaiss F, Disser M, Helmchen U, Hora K, Schlöndorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993;44:1036-47.
35. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 (MCP-1) in experimental and human glomerulonephritis. Lab Invest 1994;71:536-42.
36. Diamond JR, Kees-Folts D, Ding G, Frye J, Restrepo NC. Macrophages, monocyte chemoattractant peptide-1 and transforming growth factor-β1 in experimental hydronephrosis. Am J Physiol 1994;266:F926-33.
37. Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Taubman MB. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991; 30:F1095-101.
38. Poon M, Megyesi J, Green RS, Zhang H, Rollins BJ, Safirstein R, Taubman MB. In vivo and in vitro inhibition of the JE gene expression by glucocorticoids. J Biol Chem 1991; 266:22375-9.
39. Schiller B, Moran J. Increased severity of glomerulosclerosis in the rat puromycin aminonucleoside (PAN) model is associated with increased MCP-1 but not TGF-β expression (abstract). Kidney Int 1995;47:691.
40. Wokalek H, Ruh H. Time course of wound healing. J Biomater Appl 1991;5:337-62.
41. Whitby DJ, Ferguson MWJ. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147:207-15.
42. Krummel TM, Michna BA, Thomas BL, Sporn MB, Nelson JM, Salzberg AM, Cohen IK, Diegelmann RF. Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model. J Pediatr Surg 1988;23:647-52.
43. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β. Lancet 1992;339:213-4.
44. Beck LS, DeGuzman L, Lee WP, XuY, Siegel MW, Amento EP. One systemic administration of TGF-β1 reverses age or glucocorticoid impaired wound healing. J Clin Invest 1993; 92:2841-9.
45. Cromack DT, Porras-Reyes B, Purdy JA, Pierce GF, Mustoe TA. Acceleration of tissue repair by transforming growth factor β1: identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits. Surgery 1993; 113:36-42.
46. Leibovich SJ, Ross R. The role of macrophages in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71-100.
47. Murray JC. Scars and keloids. Dermatol Clin 1993;11: 697-708.
48. Younai S, Nichter LS, Wellisz T, Reinisch J, Nimni ME, Tuan TL. Modulation of collagen growth factor-β in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994;33: 148-54.
49. Khalil N, Berenznay O, Sporn MB, Greenberg AH. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989;131:836-43.
50. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994;153:4733-41.